University of Minnesota. Driven to Discover.
Narrow results
Response to seasonal flu, H7N9, MERS, and other threats could be markedly diminished.
A new molecular strategy could diffuse some of the controversy over lab-modified flu viruses.
Intensive federal deliberations are under way on whether to stockpile a vaccine against the H7N9 flu virus that emerged this spring in China.
The CDC's recently modified advice suggests that clinicians test only suspected H7N9 influenza patients who require hospitalization.
Get news & practices.
Sign up now»
Unrestricted financial support provided by
Become an underwriter»